BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Day One to Present at the 21st Annual Needham Virtual Healthcare Conference

  Day One Biopharmaceuticals announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 3:45 p.m. ET.

  April 6, 2022

   · 

  1 min read
• Business

  Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US

  Shenzhen Pregene Biopharma, and CellPoint, a cell therapy company developing CAR-T therapeutics for use at the point-of-care (POC), today announce an exclusive license agreement for the development and commercialization of PRG-1801.

  April 6, 2022

   · 

  5 min read
• Genetown

  NeuroSense Therapeutics Granted Patent in Canada for its ALS Drug PrimeC

  NeuroSense Therapeutics Ltd. today announced the Canadian Intellectual Property Office has granted the Company a key patent titled “Compositions comprising an anti-inflammatory drug and DICER activator for treatment of neuronal diseases” having the number 3,068,149.

  April 6, 2022

   · 

  4 min read
• Biotech Bay

  CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance

  CareDx, Inc. today announced it will host the symposium, “Improved Precision with a Multimodality Approach,” during the annual American Society of Transplantation Cutting Edge of Transplantation.

  April 6, 2022

   · 

  4 min read
• Biotech Bay

  ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022

  ASLAN Pharmaceuticals today announced that Dr Carl Firth, CEO, will present at the 21st Annual Needham Virtual Healthcare Conference.

  April 6, 2022

   · 

  1 min read
• PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility

  PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that the Company has entered into a secured loan agreement for up to $15 million with Kreos Capital VI LP.

  April 6, 2022

   · 

  7 min read
• BioMidwest

  Oral Vaccine Boosts COVID Immunity

  Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2.

  April 6, 2022

   · 

  3 min read
• Business

  Nevro to Report First Quarter 2022 Financial Results

  Company to Host Conference Call on Wednesday, May 4, 2022 at 1:30 pm PT / 4:30 pm ET.

  April 6, 2022

   · 

  2 min read
• Business

  Oncolytics Biotech® Letter to Shareholders - Update on Recent Progress

  Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) is providing a letter to shareholders.

  April 6, 2022

   · 

  13 min read
• Drug Development

  Lutris Pharma Completes Enrollment of Part Two of its Phase 1/2 Trial of LUT014 To Treat Radiation Dermatitis in Patients with Breast Cancer

  Lutris Pharma today announced that it has completed enrollment of part two of its phase 1/2 clinical trial of lead compound, LUT014.

  April 6, 2022

   · 

  4 min read